Abstract
To compare corneal higher order aberrations (HOAs) in patients with epiphora caused by unilateral primary acquired nasolacrimal duct obstruction (PANDO) and their fellow eyes. One hundred twenty two eyes of 61 patients with unilateral PANDO were included. Affected eyes named as Group 1 and contralateral eyes named as Group 2. Munk scale and fluorescein dye disappearance test (FDDT) were assessed. Corneal topographic and HOAs measurements were taken by Sirius topography. There were 47 female and 14 male patients. The mean Km were 43.84± 1.4 in Group 1 and 43.96± 1.4 in Group 2 (p=0.73). The mean corneal topographic astigmatism were 0.81± 0.7 in Group 1 and 0.78± 0.5 in Group 2 (p=0.57). The mean coma-like aberration was 0.19± 0.2 in Group 1 and 0.1± 0.1 in Group 2 (p=0.03). The mean spherical-like aberration was 0.16± 0.1 in Group 1 and 0.11± 0.1 in Group 2 (p=0.04). The mean total corneal HOA was 0.3±0.5 in Group 1 and 0.23±0.2 in Group 2 (p=0.04). The mean munk score was 3.47± 1 in Group 1. There was a positive correlation between munk score and coma-like aberration and total corneal HOAs levels (r=0.53; p=0.003 and r=0.44; p=0.01 respectively). The mean FDDT was grade 2.6± 0.1 in Group 1. There was a positive correlation between FDDT grade and coma-like aberration and total corneal HOAs levels (r=0.48; p=0.001 and r=0.33; p=0.001 respectively). Epiphora in patients with PANDO can affect corneal HOAs. As patients symptoms and tear pooling were increased corneal HOA levels increased.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.